Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

DFH Pharma and NCI enter collaboration

Jan. 13, 2012

Kadmon acquires anticancer candidate from Concordia Pharmaceuticals

Jan. 12, 2012

Forma Therapeutics enters into exclusive alliance

Jan. 12, 2012

Celtaxsys obtains anti-inflammatory drug from Estrellita Pharmaceuticals

Jan. 12, 2012

Xenon Pharmaceuticals enters alliance for pain therapeutics

Jan. 12, 2012

Leo Pharma in-licenses Virobay product

Jan. 11, 2012

Endo Pharmaceuticals and BioDelivery Sciences sign agreement for pain therapy

Jan. 11, 2012

KalVista Pharmaceuticals and JDRF enter partnership

Jan. 11, 2012

Astellas and Theravance terminate license agreement

Jan. 10, 2012

Silence Therapeutics and miRagen to collaborate on microRNA-based therapeutics

Jan. 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...